Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kageyama, Kosei  [Clear All Filters]
2023
Shimizu Y, Kaji D, Watanabe O, Yamaguchi K, Kageyama K, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto H, et al. Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study. Cancer Med. 2023.
2022
Oyama T, Kageyama K, Araoka H, Mitsuki T, Yamaguchi K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, et al. Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients. Int J Hematol. 2022.
Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, et al. Factors associated with breakthrough fungemia caused by , , or species when the breakthrough fungemia developed in patients with hematological disorders. Antimicrob Agents Chemother. 2022:AAC0208121.
2021
Yamamuro R, Kimura M, Asano-Mori Y, Abe M, Nakamura S, Umeyama T, Yamagoe S, Miyazaki Y, Ogura S, Sakoh T, et al. Clinical and microbiological characteristics of proven invasive aspergillosis due to rare/cryptic species in allogeneic hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2021:AAC0163021.
2020
Yuasa M, Yamamoto H, Mitsuki T, Kageyama K, Kaji D, Taya Y, Nishida A, Ishiwata K, Takagi S, Yamamoto G, et al. Prognostic impact of cytogenetic evolution on the outcome of allogeneic stem cell transplantation in patients with acute myeloid leukemia in non-remission: A single institute analysis of 212 recipients. Biol Blood Marrow Transplant. 2020.